Hepatic Arterial Infusion Chemotherapy Combined With Sintilimab and Regorafenib as Adjuvant Therapy for Colorectal Liver Metastasis Patients With a High Risk of Recurrent: a Single-arm, Phase II Study
Clinical trial NCT05753163 · UNKNOWN
Trial details
- NCT number
- NCT05753163
- Sponsor
- Fudan University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-02
- Primary completion
- 2024-03-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.